Avastin Information

avastin Avastin was first approved in 2004 for treatment of advanced colon cancer and has been approved since for advanced lung , kidney and brain

Avastin is a targeted therapy that may be used off-label in combination with Taxol to treat certain people with metastatic HER2-negative avastin Avastin is indicated for the treatment of patients who have not received chemotherapy for metastatic HER2-negative breast cancer in combination with paclitaxel